Earnings History Data for Checkmate Pharmaceuticals, Inc. (CMPI) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals Inc. is a clinical stage biotechnology company. It is focused on developing proprietary technology to harness the power of the immune system to combat cancer. The company's product candidate includes CMP-001, which is in clinical stage. Checkmate Pharmaceuticals Inc. is based in Cambridge, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-08-2021 | AH | CMPI | Checkmate Pharmaceuticals, Inc. | 112.00 | -0.88 | -0.94 | 0.00 | Checkmate Pharmaceuticals EPS misses by $0.14 [8/12/2021 5:17 PM] |
5.14 | -0.16 (-3.02%) |
0.0 | 0.0 (0.00%) |
5.00 - 23.10 | 5,992 | 20,000 | 0 | ||
| 13-05-2021 | AH | After the close (May 13) |
CMPI | Checkmate Pharmaceuticals, Inc. | 132.00 | -0.65 | -0.75 | 0.00 | Checkmate Pharmaceuticals EPS beats by $0.02 [5/13/2021 5:25 PM] |
6.60 | 0.43 (6.97%) |
6.25 | 0.08 (1.30%) |
5.84 - 23.10 | 34,658 | 60,000 | 105 | |
| 13-11-2020 | PM | CMPI | Checkmate Pharmaceuticals, Inc. | 245.00 | -0.84 | -0.40 | 0.00 | Checkmate Pharmaceuticals reports Q3 results [11/13/2020 7:22 AM] |
10.72 | 0.0 (0.05%) |
0.0 | 0.0 (0.00%) |
8.61 - 16.49 | 10,986 | 15,927 | 0 | ||
|
|
||||||||||||||||||